Temozolomide and oral etoposide in children with recurrent malignant brain tumors
Despite advances in the treatment of brain tumors, the prognosis of children with recurrent malignant brain tumors remains poor. Etoposide (VP-16), an inhibitor of nuclear enzyme deoxyribonucleic acid (DNA)-topoisomerase II, has shown activity in brain tumors. Its efficacy appears schedule dependent...
Saved in:
Main Authors: | Antonio Ruggiero (Author), Anna Ariano (Author), Silvia Triarico (Author), Michele Antonio Capozza (Author), Alberto Romano (Author), Palma Maurizi (Author), Stefano Mastrangelo (Author), Giorgio Attinà (Author) |
---|---|
Format: | Book |
Published: |
BioExcel Publishing Ltd,
2020-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Multifocal infantile haemangiomatosis with hepatic involvement: two cases and treatment management
by: Antonio Ruggiero, et al.
Published: (2020) -
Transdermal buprenorphine for pain management in children
by: Giorgio Attinà, et al.
Published: (2021) -
Neonatal pharmacology and clinical implications
by: Antonio Ruggiero, et al.
Published: (2019) -
Aminoglycosides-Related Ototoxicity: Mechanisms, Risk Factors, and Prevention in Pediatric Patients
by: Serena Rivetti, et al.
Published: (2023) -
Neonatal outcomes and follow-up of children born to women with pregnancy-associated cancer: a prospective observational study
by: Michele Antonio Capozza, et al.
Published: (2024)